同仁堂(600085.SH)子公司获得药品GMP证书
格隆汇7月19日丨同仁堂(600085.SH)公布,公司于近日获悉,子公司北京同仁堂科技(01666.HK)所属制药厂经过现场检查和技术审核,符合《药品生产质量管理规范》要求,收到北京市药品监督管理局颁发的《药品GMP证书》。证书编号:BJ20190432,认证范围:中药前处理、中药前处理、丸剂(蜜丸、水蜜丸),有效期至:2024年7月7日。
此次同仁堂科技所属制药厂生产线通过GMP认证并获发《药品GMP证书》,表明同仁堂科技相关生产线满足GMP要求,此次《药品GMP证书》的获得,有利于其加快工业布局调整、完善产业链条、解决产能瓶颈。此次同仁堂科技获得《药品GMP证书》不会对公司业绩产生重大影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.